Karim Chamie

Dr. Karim Chamie is an Associate Professor of Urology at the University of California, Los Angeles (UCLA) specializing in urologic oncology with a focus on bladder cancer. He practices at Westwood Urology in Los Angeles and has hospital affiliations with Ronald Reagan UCLA Medical Center and UCLA Santa Monica Medical Center. His clinical expertise includes minimally invasive urology, robotic surgery, and comprehensive care for bladder, prostate, and kidney cancers.

Dr. Chamie's educational background includes:

• MD from Keck School of Medicine of the University of Southern California (2003)
• Surgical Internship at UC Davis Health (2004)
• Surgical Residency at UC Davis Health (2005)
• Urology Residency at UC Davis Health (2009)
• Urologic Oncology Fellowship at UCLA School of Medicine (2012)
• Board Certification in Urology from the American Board of Urology (2015)

Dr. Chamie's primary research interests focus on health services research and clinical trials in bladder cancer. His work examines treatment patterns, healthcare disparities, and quality of care in urologic oncology. He has a particular interest in robotic surgery applications for bladder cancer treatment and novel therapeutic approaches for non-muscle invasive and advanced bladder cancer. His research bridges clinical practice with healthcare policy to improve patient outcomes and access to care.

Dr. Chamie's publication record demonstrates a strong focus on bladder cancer research, with numerous articles on clinical management, systemic therapies, and surgical innovations. His recent work emphasizes immunotherapy approaches, novel drug delivery mechanisms, and quality of care metrics in bladder cancer treatment. The trend in his publications shows increasing emphasis on translational research that connects laboratory findings with clinical applications, particularly in the areas of robotic surgery and targeted therapies for urothelial carcinoma.

Dr. Chamie has received numerous professional recognitions:

• Top Doctors, Los Angeles Magazine (2021)
• Dean's Scholar, University of Southern California Keck School of Medicine
• Baxter Academic Scholarship
• Gerber Academic Scholarship
• Northern California Urological Association Resident Research Award (1st Place)
• Gerald P. Murphy Award, American Urological Association
• Best reviewer in 2011 Award for the Journal of Urology

As an active researcher and clinician, Dr. Chamie participates in multiple clinical trials for bladder cancer treatment, including studies of intravesical enfortumab vedotin for non-muscle invasive bladder cancer and combination therapies for advanced disease. His work as a principal investigator and co-investigator demonstrates his commitment to advancing the field through rigorous clinical research. While specific grant details aren't provided in the source material, his active participation in clinical trials suggests substantial research funding support.

Dr. Chamie is affiliated with the Jonsson Comprehensive Cancer Center (JCCC) at UCLA, which provides a collaborative environment for cancer research and treatment. His work involves multidisciplinary teams including medical oncologists, radiation oncologists, pathologists, and basic science researchers to develop comprehensive approaches to urologic cancers. His clinical practice at Westwood Urology serves as both a treatment center and a site for clinical research translation.